Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity

M Yousuf, S Khan, A Hussain, MF Alajmi… - International Journal of …, 2024 - Elsevier
Abstract Cyclin-dependent kinase 6 (CDK6) participates in numerous signalling pathways
and regulates various physiological processes. Due to its unique structural features and …

Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 Inhibitors

P Niu, Y Tao, G Lin, H Xu, Q Meng, K Yang… - Journal of Medicinal …, 2024 - ACS Publications
The duality of function (cell cycle regulation and gene transcription) of cyclin-dependent
kinase 7 (CDK7) makes it an attractive oncology target and the discovery of CDK7 inhibitors …

Inhibiting CDK6 activity by quercetin is an attractive strategy for cancer therapy

M Yousuf, P Khan, A Shamsi, M Shahbaaz… - ACS …, 2020 - ACS Publications
Cyclin-dependent kinase 6 (CDK6) is a potential drug target that plays an important role in
the progression of different types of cancers. We performed in silico and in vitro screening of …

A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9

A Atiya, H Shahidi, T Mohammad… - Journal of …, 2023 - Taylor & Francis
Abstract Cyclin-dependent kinase 9 (CDK9) is a transcription-associated protein involved in
controlling the cell cycle and is often deregulated in stress conditions. CDK9 is being studied …

Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy

T Mohammad, S Batra, R Dahiya, MH Baig, IA Rather… - Molecules, 2019 - mdpi.com
Cyclin-dependent kinase 2 (CDK2) is an essential protein kinase involved in the cell cycle
regulation. The abnormal activity of CDK2 is associated with cancer progression and …

Discovery of SHR5428 as a selective and noncovalent inhibitor of CDK7

M Jia, W Wang, G Chen, T Wu, T Zhang, Q Zhou… - Bioorganic & Medicinal …, 2023 - Elsevier
Abstract Cyclin dependent kinase 7 (CDK7) is an attractive target in tumor indications via
regulating both cell cycle and transcription. Here, SHR5428 was discovered as a selective …

Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics

M Yousuf, A Shamsi, S Khan, P Khan… - International Journal of …, 2022 - Elsevier
Cancer is one of the major causes of global deaths and needs immediate therapeutic
development. So far, several strategies have been undertaken to prevent cancer, including …

Identification of CDK7 inhibitors from natural sources using pharmacoinformatics and molecular dynamics simulations

V Kumar, S Parate, G Thakur, G Lee, HS Ro, Y Kim… - Biomedicines, 2021 - mdpi.com
The cyclin-dependent kinase 7 (CDK7) plays a crucial role in regulating the cell cycle and
RNA polymerase-based transcription. Overexpression of this kinase is linked with various …

Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies

M Yousuf, A Shamsi, A Queen… - Journal of Cellular …, 2021 - Wiley Online Library
Abstract Cyclin‐dependent kinase 6 (CDK6) is a member of serine/threonine kinase family,
and its overexpression is associated with cancer development. Thus, it is considered as a …

Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches

X Luo, Y Zhao, P Tang, X Du, F Li, Q Wang, R Li… - Molecular Diversity, 2021 - Springer
Excessive cell proliferation due to cell cycle disorders is one of the hallmarks of breast
cancer. Cyclin-dependent kinases (CDKs), which are involved in the transition of the cell …